Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes - Rosenstock, J; Jelaska, A; Frappin, G (Diabetes Care, 2014)
et al.